O
12.89
-0.10 (-0.77%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看涨 |
| Biotechnology (全球的) | 混合的 | 看涨 | |
| 股票 | Oric Pharmaceuticals, Inc. | 混合的 | 看涨 |
AIStockmoo 评分
-2.9
| 分析师共识 | NA |
| 内部交易活动 | -1.5 |
| 价格波动 | -4.5 |
| 技术平均移动指标 | -5.0 |
| 技术振荡指标 | -0.5 |
| 平均 | -2.88 |
|
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Core |
| 内部持股比例 | 7.93% |
| 机构持股比例 | 102.70% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Aihc Capital Management Ltd | 30 Jun 2026 | 3,828,460 |
| Column Group Llc | 30 Jun 2026 | 3,540,777 |
该时间范围内无数据。
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| PISCITELLI DOMINIC | - | 13.91 | -77,000 | -1,071,070 |
| 累积净数量 | -77,000 | |||
| 累积净值 ($) | -1,071,070 | |||
| 累积平均购买 ($) | - | |||
| 累积平均卖出 ($) | 13.91 | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| PISCITELLI DOMINIC | 职员 | 26 Aug 2026 | 自动卖出 (-) | 77,000 | 13.91 | 1,071,070 |
| PISCITELLI DOMINIC | 职员 | 26 Aug 2026 | 执行期权 | 77,000 | - | - |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合